GENEREX BIOTECHNOLOGY CORP (GNBT) has 24 open-market insider trades by 8 insiders since 2006. The most active filer is Mark Fletcher, President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Mark Fletcher | Pres | — | 6 | $291K | 2016-02-16 |
| Brian McGee | Dir | — | 2 | $238K | 2014-10-06 |
| Stephen Fellows | CFO | — | 2 | $150K | 2013-06-18 |
| Rose C. Perri | Dir | — | 6 | $42K | 2011-05-09 |
| Nola E. Masterson | Dir | — | 4 | $35K | 2012-07-03 |
| Harold Gray Haines | — | — | 2 | $12K | 2018-12-07 |
| Settle Mindy J. Allport | Dir | — | 1 | $10K | 2006-05-30 |
| Anna E. Gluskin | CEO & Pres. | — | 1 | — | 2019-11-16 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Anna E. Gluskin | CEO & Pres. | Buy | — | 2019-11-16 |
| Harold Gray Haines | — | Buy | $9K | 2018-12-07 |
| Harold Gray Haines | — | Buy | $3K | 2018-12-04 |
| Stephen Fellows | CFO | Sell | $101K | 2013-06-18 |
| Stephen Fellows | CFO | Sell | $49K | 2012-06-25 |
| Rose C. Perri | Director | Sell | $3K | 2011-05-09 |
Companies that share insiders with GNBT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Rose C. Perri | Director | Sell | $5K | 2011-05-06 |
| Rose C. Perri | Director | Sell | $6K | 2011-05-03 |
| Mark Fletcher | — | Buy | $5K | 2011-04-06 |
| Rose C. Perri | COO & CFO& Treas. | Buy | $19K | 2010-10-27 |
| Mark Fletcher | EVP & General Counsel | Buy | $5K | 2010-01-04 |
| Rose C. Perri | COO & CFO +1 | Buy | $5K | 2009-11-16 |
| Nola E. Masterson | Director | Buy | $5K | 2009-11-13 |
| Nola E. Masterson | Director | Sell | $25K | 2009-11-12 |
| Nola E. Masterson | Director | Sell | $2K | 2009-10-19 |